• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中的膜磷脂改变:乙醇胺缩醛磷脂缺乏

Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens.

作者信息

Farooqui A A, Rapoport S I, Horrocks L A

机构信息

Department of Medical Biochemistry, Ohio State University, Columbus 43210, USA.

出版信息

Neurochem Res. 1997 Apr;22(4):523-7. doi: 10.1023/a:1027380331807.

DOI:10.1023/a:1027380331807
PMID:9130265
Abstract

The ethanolamine plasmalogens are decreased whereas serine glycerophospholipids are significantly increased in plasma membrane phospholipid in affected regions of brain in Alzheimer's disease. This may be due to stimulation of Ca(2+)-independent plasmalogen-selective phospholipase A2 which was recently discovered in brain. This phospholipase A2 differs from other Ca(2+)-independent phospholipases A2 in response to ATP and various inhibitors. It may be responsible for excess release of arachidonic acid and accumulation of prostaglandins and lipid peroxides in AD. Accumulation of the above lipid metabolites due to abnormal receptor function and signal transduction may contribute to neurodegeneration in AD.

摘要

在阿尔茨海默病患者大脑的病变区域,乙醇胺缩醛磷脂减少,而丝氨酸甘油磷脂在质膜磷脂中显著增加。这可能是由于最近在大脑中发现的不依赖钙离子的缩醛磷脂选择性磷脂酶A2受到刺激所致。这种磷脂酶A2在对ATP和各种抑制剂的反应方面不同于其他不依赖钙离子的磷脂酶A2。它可能是导致花生四烯酸过度释放以及前列腺素和脂质过氧化物在阿尔茨海默病中积累的原因。由于受体功能和信号转导异常导致上述脂质代谢产物的积累,可能会促使阿尔茨海默病中的神经退行性变。

相似文献

1
Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens.阿尔茨海默病中的膜磷脂改变:乙醇胺缩醛磷脂缺乏
Neurochem Res. 1997 Apr;22(4):523-7. doi: 10.1023/a:1027380331807.
2
Plasmalogens, phospholipase A2, and docosahexaenoic acid turnover in brain tissue.脑组织中的缩醛磷脂、磷脂酶A2和二十二碳六烯酸代谢
J Mol Neurosci. 2001 Apr-Jun;16(2-3):263-72; discussion 279-84. doi: 10.1385/jmn:16:2-3:263.
3
Breakdown of membrane phospholipids in Alzheimer disease. Involvement of excitatory amino acid receptors.
Mol Chem Neuropathol. 1995 Jun-Aug;25(2-3):155-73. doi: 10.1007/BF02960910.
4
Plasmalogen-selective phospholipase A2 and its involvement in Alzheimer's disease.缩醛磷脂选择性磷脂酶A2及其在阿尔茨海默病中的作用。
Biochem Soc Trans. 1998 May;26(2):243-6. doi: 10.1042/bst0260243.
5
Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia.缩醛磷脂:正常及受损神经元和神经胶质细胞中膜的主要脂质
Neuroscientist. 2001 Jun;7(3):232-45. doi: 10.1177/107385840100700308.
6
Plasmalogen-selective phospholipase A2 and its role in signal transduction.缩醛磷脂选择性磷脂酶A2及其在信号转导中的作用。
J Lipid Mediat Cell Signal. 1996 Sep;14(1-3):9-13. doi: 10.1016/0929-7855(96)01502-7.
7
Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity.阿尔茨海默病中的磷脂代谢酶:溶血磷脂酰转移酶活性增加,磷脂酶A2活性降低。
J Neurochem. 1998 Feb;70(2):786-93. doi: 10.1046/j.1471-4159.1998.70020786.x.
8
Signaling events mediating activation of brain ethanolamine plasmalogen hydrolysis by ceramide.
Eur J Biochem. 2003 Jan;270(1):36-46. doi: 10.1046/j.1432-1033.2003.03356.x.
9
Selective hydrolysis of plasmalogen phospholipids by Ca2+-independent PLA2 in hypoxic ventricular myocytes.缺氧心室肌细胞中不依赖Ca2+的磷脂酶A2对缩醛磷脂的选择性水解作用。
Am J Physiol. 1998 Jun;274(6):C1727-37. doi: 10.1152/ajpcell.1998.274.6.C1727.
10
Calcium-independent phospholipase A2-catalyzed plasmalogen hydrolysis in hypoxic human coronary artery endothelial cells.
Am J Physiol Cell Physiol. 2007 Jan;292(1):C251-8. doi: 10.1152/ajpcell.00120.2006. Epub 2006 Aug 30.

引用本文的文献

1
Plasmalogen as a Bioactive Lipid Drug: From Preclinical Research Challenges to Opportunities in Nanomedicine.缩醛磷脂作为一种生物活性脂质药物:从临床前研究挑战到纳米医学机遇
FASEB Bioadv. 2025 Jun 4;7(8):e70028. doi: 10.1096/fba.2025-00010. eCollection 2025 Aug.
2
Benchmarking of Trapped Ion Mobility Spectrometry in Differentiating Plasmalogens from Other Ether Lipids in Lipidomics Experiments.脂质组学实验中用于区分缩醛磷脂与其他醚脂的捕获离子淌度光谱法的基准测试
Anal Chem. 2025 May 27;97(20):10578-10587. doi: 10.1021/acs.analchem.4c06617. Epub 2025 May 13.
3
Lipidome disruption in Alzheimer's disease brain: detection, pathological mechanisms, and therapeutic implications.

本文引用的文献

1
Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain.胞质型磷脂酶A2(cPLA2)免疫反应性在阿尔茨海默病大脑中升高。
Neurobiol Dis. 1996 Feb;3(1):51-63. doi: 10.1006/nbdi.1996.0005.
2
Plasmalogens, phospholipases A2 and signal transduction.缩醛磷脂、磷脂酶A2与信号转导
Brain Res Brain Res Rev. 1995 Sep;21(2):152-61. doi: 10.1016/0165-0173(95)00008-9.
3
Neural membrane phospholipids in Alzheimer disease.阿尔茨海默病中的神经膜磷脂
阿尔茨海默病大脑中的脂质组破坏:检测、病理机制及治疗意义
Mol Neurodegener. 2025 Jan 27;20(1):11. doi: 10.1186/s13024-025-00803-6.
4
Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease.脑灰质和白质单半乳糖基二甘油酯水平随阿尔茨海默病的进展而升高。
J Alzheimers Dis. 2023;95(4):1623-1634. doi: 10.3233/JAD-230543.
5
Brain ethanolamine phospholipids, neuropathology and cognition: A comparative post-mortem analysis of structurally specific plasmalogen and phosphatidyl species.脑乙醇胺磷脂、神经病理学与认知:结构特异性缩醛磷脂和磷脂酰种类的比较尸检分析
Front Cell Dev Biol. 2022 Aug 24;10:866156. doi: 10.3389/fcell.2022.866156. eCollection 2022.
6
Cholesterol as a key player in amyloid β-mediated toxicity in Alzheimer's disease.胆固醇在阿尔茨海默病中淀粉样蛋白β介导的毒性作用中扮演关键角色。
Front Mol Neurosci. 2022 Aug 25;15:937056. doi: 10.3389/fnmol.2022.937056. eCollection 2022.
7
Targeted Lipidomics To Measure Phospholipids and Sphingomyelins in Plasma: A Pilot Study To Understand the Impact of Race/Ethnicity in Alzheimer's Disease.靶向脂质组学测量血浆中的磷脂和神经鞘磷脂:一项理解阿尔茨海默病中种族/民族影响的初步研究。
Anal Chem. 2022 Mar 15;94(10):4165-4174. doi: 10.1021/acs.analchem.1c03821. Epub 2022 Mar 2.
8
Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer's Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue.为什么 DHA 在阿尔茨海默病的治疗和预防方面没有效果?一篇重点关注 DHA 代谢和脂肪组织的叙述性综述
Int J Mol Sci. 2021 Oct 31;22(21):11826. doi: 10.3390/ijms222111826.
9
Structure-specific, accurate quantitation of plasmalogen glycerophosphoethanolamine.特异性结构、准确定量的溶血磷脂酰乙醇胺。
Anal Chim Acta. 2021 Nov 22;1186:339088. doi: 10.1016/j.aca.2021.339088. Epub 2021 Sep 22.
10
Reassessment of Pioglitazone for Alzheimer's Disease.吡格列酮用于阿尔茨海默病的重新评估
Front Neurosci. 2021 Jun 16;15:666958. doi: 10.3389/fnins.2021.666958. eCollection 2021.
Neurochem Res. 1995 Nov;20(11):1329-33. doi: 10.1007/BF00992508.
4
Deleterious network hypothesis of Alzheimer's disease.阿尔茨海默病的有害网络假说
Med Hypotheses. 1996 May;46(5):421-8. doi: 10.1016/s0306-9877(96)90021-3.
5
Changes in brain membrane phospholipid and high-energy phosphate metabolism precede dementia.脑膜磷脂和高能磷酸代谢的变化先于痴呆症出现。
Neurobiol Aging. 1995 Nov-Dec;16(6):973-5. doi: 10.1016/0197-4580(95)02017-9.
6
Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain.阿尔茨海默病大脑中乙醇胺缩醛磷脂缺乏的疾病及解剖学特异性。
Brain Res. 1995 Nov 6;698(1-2):223-6. doi: 10.1016/0006-8993(95)00931-f.
7
Breakdown of membrane phospholipids in Alzheimer disease. Involvement of excitatory amino acid receptors.
Mol Chem Neuropathol. 1995 Jun-Aug;25(2-3):155-73. doi: 10.1007/BF02960910.
8
Quantitative synaptic alterations in the human neocortex during normal aging.正常衰老过程中人类新皮层的定量突触改变。
Neurology. 1993 Jan;43(1):192-7. doi: 10.1212/wnl.43.1_part_1.192.
9
Platelet-activating factor: receptors and signal transduction.血小板活化因子:受体与信号转导
Biochem J. 1993 Jun 15;292 ( Pt 3)(Pt 3):617-29. doi: 10.1042/bj2920617.
10
Evidence for a membrane lipid defect in Alzheimer disease.阿尔茨海默病中膜脂质缺陷的证据。
Mol Chem Neuropathol. 1993 May-Jun;19(1-2):37-46. doi: 10.1007/BF03160167.